Changes in plant type and in production systems 
(such as directseeding) have resulted in an increase in sheath blight 
(Rhizoctonia solani) in rice in Malaysia. This is the major rice disease in many 
regions/countries, causing more losses than any other fungal disease, especially 
in the lowland tropics. The soil-borne fungal pathogen spreads via its sclerotia 
and mycelium and, if conditions are favourable, can infect the entire plant – 
from the base of the stem to the panicle. If infection is severe and occurs at 
an early stage of crop growth, the pathogen penetrates the stem, turning its 
tissues into a mush and preventing the transport of water and nutrients within 
the plant. This results in severe impairment of yield and quality (stunted 
grains and a low proportion of milled rice). High temperature and humidity 
encourage the development of the disease, especially during the early heading 
stages. Higher crop densities result in a more humid microclimate, promoting 
infection. Closer contact between the plants also promotes the spread of 
infection in the dense canopy. Helminthosporium brown spot (H. oryzae) is a 
common disease of rice in almost all countries where the crop is grown. The 
pathogen’s airborne conidia are an important source of inoculum. The disease can 
occasionally become a serious problem, especially when it occurs together with 
sheath blight at the heading stage of the crop. The application of 
Monceren® (pencycuron) 25 WP or 250 SC for initial sheath blight 
control, followed by a Flint 50 WG application at 100 g/ha to control both 
sheath blight and Helminthosporium leaf spot, is a favourable spray programme. 
In direct-seeded rice fields, fish farming is rendered impractical due to the 
high density of plants. Moreover, application of Flint 50 WG is timed at about 
65-70 days after sowing, when the field is practically without water so aquatic 
organisms are unlikely to be affected. Further trials with Flint 50 WG against 
major diseases in fruit and other vegetable crops towards appropriate disease 
management 
 
没有评论:
发表评论